Stockreport

Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com
PDF Cash from Operations: Approximately $400 million in Q3, roughly $1 billion year-to-date. Cash and Cash Equivalents: $2.6 billion. Xywav Net Product Sales: $388 mill [Read more]